Diagnos Laboratorium Utama Tbk. vs Lancartama Sejati Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 319B, 7.6K 24h volume), while Lancartama Sejati Tbk. trades at Rp268 (market cap 314.4B, 12.67M 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. and Lancartama Sejati Tbk. are close in size by market cap, and Lancartama Sejati Tbk. is more actively traded (12.67M versus 7.6K). Which is the better fit depends on your goals.
| DGNS | TAMA | |
|---|---|---|
Market Cap | 319B | 314.4B |
Volume | 7.6K | 12.67M |
Lot | 76 | 126.73K |
Turnover | 1.74M | 3.42B |
Average Price | 229.21 | 269.61 |
Value | 1.74M | 3.42B |
Indicative Equilibrium Price | 232 | 264 |
Indicative Equilibrium Volume | 200 | 2.26K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Lancartama Sejati Tbk (the Company) was established based on notary deed No. 12 dated June 01, 1990 of Sugiri Kadarisman, SH., notary in Jakarta.
Read more on TAMA →